BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 1st Quarter - Report

VERAX BIOMEDICAL

via S-3 GROUP

1st Quarter (Jan 1 - Mar 31) · 2023Posted Apr 20, 2023Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: VERAX BIOMEDICAL
Description: Medical product developer
Location: Massachusetts · United States of America

Registrant

Firm: S-3 GROUP
Description: Government consulting firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to blood safety
LobbyistsMARTIN DELGADO · MATT BRAVO · KEVIN CASEY · RICHARD CARBO · mr MARTIN REISER
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

VERAX BIOMEDICAL — Lobbying — Receipts Report